Carl Zeiss Meditec AG reported Tuesday that it has issued 8,130,960 new shares, a ten percent increase in share capital, in order to raise cash for acquisitions. The per share price was €38.94, resulting in a total increase of available cash reserves of €317 million. The shares were offered exclusively to institutional investors and will carry full dividend rights for the past fiscal year.
Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec, said in the statement: “We are delighted with the very strong demand for our new shares. The realised proceeds will provide us with the necessary firepower and flexibility to selectively exploit opportunities in our markets and to sustainably accelerate our growth. We would like to thank our new and existing shareholders for the high level of trust.”
